Hypofibrinolysis and other hemostatic defects in women with early reproductive failure;Hipofibrinolisis y otros defectos de la hemostasia en mujeres con antecedentes de fallas reproductivas tempranas

Medicina

Volumn 60, Issue 4, 2000, Pages 441-447

  Sarto, Adriana ^a   Rocha, Marta ^a   Martinez, Marcelo ^a   Pasqualini, R Sergio ^a  

^a Halitus Instituto Medico   (Argentina)

Author keywords

Early reproductive failure; Fibrinolytic defects; Implantation failure; Recurrent pregnancy loss; Thrombophilic defects

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; FEMALE; FEMALE INFERTILITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFERTILITY THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATION; PREVALENCE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; BIOLOGICAL MARKERS; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; INFERTILITY, FEMALE; PREGNANCY COMPLICATIONS; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES;

EID: 0034569069     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Molo MW, Kelly M, Balos R. Incidence of fetal loss in infertility patients after detection of fetal heart activity with early transvaginal ultrasound. J Reprod Med 1993; 10: 804-6.
2. Coulam CB: Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26. 23-7.
3. Kutteh WH, Pasquarette M. Recurrent pregnancy loss. Adv Obstet Gynecol 1995; 2: 147-77.
4. Coulam CB, Clark D, Beer A, et al. Current Clinical Options for Diagnosis and Treatment of Recurrent Spontaneous Abortion. 1997 AJRI 38: 57-74.
5. Gris JC, Schevd JF, Neveu S, Mares P, Aguilar-Martínez P, Dupaigne D. Impaired fibrinolytic capacity and early, recurrent spontaneous abortion. BMJ 1990; 300: 1500.
6. Patrassi GM, Sartori MT, Ruffatti A, et al. Fibrinolytic pattern in recurrent spontaenous abortions. No relationship between hypofibrinolysis and anti-phospholipid antibodies. Am J Hemat 1994; 47: 266-72.
7. Gris JC, Neveu S, Mares P, Biron C, Heon B, Schved JF. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993; 122: 606-15.
8. Gris JC, Ripart-Neveu S, Maugard C, et al. Prospective evaluation of the prevalence of abnormalities in unexplained primary early recurrent miscarriages. (NOHA Study). Thromb Haemost 1997; 77: 1096-103.
9. Yetman and Kutteh. Antiphospholipid antibody panels and recurrent pregnancy loss. Fertil Steril 1996; 66: 540-6.
10. Triplett DA, Harris AN. Antiphospholipid antibodies and reproduction. AMJ Reprod Immunol 1989; 21: 123-31.
11. Infante-Rivard C, David M, Gauthier R, et al. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-controlled study. N Engl J Med 1991; 325: 1063-6.
12. Schved JF, Gris JC, Neveu S, Dupaigne D, Mares P. Factor XII congenital deficiency and early spontaneous abortion. Fertl Steril 1989; 52: 335-6.
13. Grandone E, Margaglione M, Colaizzo D, Addedda M, Cappucci J, Vecchione N, et al. Factor V Leiden is associated with repeated and recurrent unexplains fetal losses. Thromb Haemost 1997; 77: 822-4.
14. Estelles A, Gilabert J, España F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991; 165: 138.
15. Atiomo W, Bates S, Condon J, Shaw S, Wewst J, Prentice A. The plasminogen activator system in women with polycystic ovary syndrome. Fertility Sterility 1998; 69: 236-41.
16. Gilabert J, Estellés A, España F et al. Modificaciones de la hemostasia en obstetricia. Rev Iberoamer Tromb Hemostasia 1995; 8: 102-12.
17. Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975; 6: 379-86.
18. Ny T, Peng R, et al. Hormonal regulation of the fibrinolytic components in the ovary. Throm Res 1993; 71: 1-45.
19. Simon C. Molecular mechanism of implantation and assessment of uterin receptivity. Annual posgraduate program. Immunology Reproductive Medicine. San Francisco, California 1998; 89-103.
20. Deaumont JL: Syndrome hemorrhagique acquis du a un anticoagulant. Circulant Sang 1954, 25: 1-25.
21. Lockshin MD. Antiphospholipid antibody. JAMA 1997; 277: 1549-51.
22. Rand JH et al. Pregnancy loss in the antiphospholipid antibody syndrome a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-60.
23. Silver RM et al. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83: 372-7.
24. Said PB, Martinuzzo M, Carreras LO. Fisiopatología del síndrome antifosfolipídico. Sangre 1993; 38: 131-8.
25. Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-7.
26. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1-6.
27. Silver RK, MacGregar SN, Small JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin-antibody positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411-7.
28. Hasegawa I, Takakiwa K, Goto S, et al. Effectiveness of prednisone/aspirin therapy for recurrent aborters with antiphospholipid antibody. Hum Reprod 1992; 7: 203-7.
29. Christiansen OB, Mathiesen O, Grunnet N. Intravenous immunoglobulin treatment of women with multiple miscarriages. Hum Reprod 1992; 7: 718-22.
30. The German RSA/IVIg Group. Intravenous immunoglobulin in prevent of recurrent miscarriage. Br J Obstet Gynecol 1994; 101: 1072-7.
31. Coulman CB, Stephenson M, Stern JJ, et al. Inmunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod Immunol 1996; 35: 352-9.
32. Magid M, Kaplan C, Sammaritano L, Placental patthology in systemic lupus erythematosus. A prospective study. Am J Obstet Gynecol 1998; 179: 226-34.
33. Preston FE, Rosendaal FR, et al. Increased fetal loss in women with heritable thrombophilia. EPCOT Study. Lancet 1996; 348: 913-6.
34. Kutteh W. Autoimmune testing in reproductive failure. Immunology in Reproductive Medicine. Sixteenth World Congress on Fertility and Sterility, San Francisco, CA 1998; 133-73.